We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · September 17, 2014

Telcagepant for Migraine Preventive Therapy

Neurology

 

Additional Info

Neurology
Randomized Controlled Trial of the CGRP Receptor Antagonist Telcagepant for Migraine Prevention
Neurology 2014 Sep 09;83(11)958-966, TW Ho, KM Connor, Y Zhang, E Pearlman, J Koppenhaver, X Fan, C Lines, L Edvinsson, PJ Goadsby, D Michelson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading